{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:09:07Z","timestamp":1792130947153,"version":"4.4.0"},"reference-count":205,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>MicroRNAs (miRNAs) play a critical role in the regulation of mRNA stability and translation. In spite of our present knowledge on the mechanisms of mRNA regulation by miRNAs, the utilization and translation of these ncRNAs into clinical applications have been problematic. Using hsa-miR-429 as an example, we discuss the limitations encountered in the development of efficient miRNA-related therapies and diagnostic approaches. The miR-200 family members, which include hsa-miR-429, have been shown to be dysregulated in different types of cancer. Although these miR-200 family members have been shown to function in suppressing epithelial-to-mesenchymal transition, tumor metastasis, and chemoresistance, the experimental results have often been contradictory. These complications involve not only the complex networks involving these noncoding RNAs, but also the problem of identifying false positives. To overcome these limitations, a more comprehensive research strategy is needed to increase our understanding of the mechanisms underlying their biological role in mRNA regulation. Here, we provide a literature analysis of the verified hsa-miR-429 targets in various human research models. A meta-analysis of this work is presented to provide better insights into the role of hsa-miR-429 in cancer diagnosis and any potential therapeutic approach.<\/jats:p>","DOI":"10.3390\/cancers15112903","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T02:00:55Z","timestamp":1684980055000},"page":"2903","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8063-1272","authenticated-orcid":false,"given":"Sylwia","family":"Bartoszewska","sequence":"first","affiliation":[{"name":"Department of Inorganic Chemistry, Medical University of Gdansk, 80-416 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"S\u0142awski","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Collawn","sequence":"additional","affiliation":[{"name":"Department of Cell, Developmental and Integrative Biology, University of Alabama, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2864-6757","authenticated-orcid":false,"given":"Rafal","family":"Bartoszewski","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"Micrornas: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1101\/gad.862301","article-title":"RNA interference is mediated by 21- and 22-nucleotide RNAs","volume":"15","author":"Elbashir","year":"2001","journal-title":"Genes Dev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.171251798","article-title":"Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems","volume":"98","author":"Caplen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as Therapeutics for Gene Silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.1096\/fj.201900600RR","article-title":"MiR-34c-5p modulates X-box-binding protein 1 (XBP1) expression during the adaptive phase of the unfolded protein response","volume":"33","author":"Bartoszewska","year":"2019","journal-title":"FASEB J."},{"key":"ref_9","first-page":"17","article-title":"SiRNA- and miRNA-based therapeutics for liver fibrosis","volume":"214","author":"Zhao","year":"2019","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fphar.2019.00488","article-title":"Enhanced inhibition of tumorigenesis using combinations of miRNA-targeted therapeutics","volume":"10","author":"Miroshnichenko","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-8624-8_14","article-title":"Targeting miRNA for therapeutics using a micronome based method for identification of miRNA-mRNA pairs and validation of key regulator miRNA","volume":"1823","author":"Bansal","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.2174\/138161282339180212095249","article-title":"Editorial: Towards miRNA based therapeutics for lung cancer","volume":"23","author":"Li","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.2174\/1381612823666170714151715","article-title":"MiRNA-based therapeutics for lung cancer","volume":"23","author":"Wu","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnmol.2016.00129","article-title":"Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review","volume":"9","author":"Wen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E918","DOI":"10.21037\/jtd.2016.08.93","article-title":"Developing miRNA therapeutics for cardiac repair in ischemic heart disease","volume":"8","author":"Zhu","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1080\/15384101.2015.1093711","article-title":"miRNA-182 and the regulation of the glioblastoma phenotype\u2014Toward miRNA-based precision therapeutics","volume":"14","author":"Kouri","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","article-title":"Exploring miRNA based approaches in cancer diagnostics and therapeutics","volume":"98","author":"Mishra","year":"2016","journal-title":"Crit. Rev. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.4155\/fmc.15.107","article-title":"miRNA therapeutics: A new class of drugs with potential therapeutic applications in the heart","volume":"7","author":"Bernardo","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fgene.2015.00232","article-title":"miRNA therapeutics in cardiovascular diseases: Promises and problems","volume":"6","author":"Nouraee","year":"2015","journal-title":"Front. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/CS20140005","article-title":"Targeted delivery of miRNA therapeutics for cardiovascular diseases: Opportunities and challenges","volume":"127","author":"Kwekkeboom","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drudis.2012.10.002","article-title":"Delivering the promise of miRNA cancer therapeutics","volume":"18","author":"Pereira","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.leukres.2005.09.006","article-title":"Using synthetic miRNA mimics for diverting cell fate: A possibility of miRNA-based therapeutics?","volume":"30","author":"Ford","year":"2006","journal-title":"Leuk. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s11658-017-0054-0","article-title":"miR-200b downregulates CFTR during hypoxia in human lung epithelial cells","volume":"22","author":"Bartoszewska","year":"2017","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11658-016-0017-x","article-title":"Posttranscriptional and transcriptional regulation of endothelial nitric-oxide synthase during hypoxia: The role of microRNAs","volume":"21","author":"Kalinowski","year":"2016","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06765","article-title":"Sequence- and target-independent angiogenesis suppression by siRNA via TLR3","volume":"452","author":"Kleinman","year":"2008","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1164\/rccm.201002-0221OC","article-title":"Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus","volume":"182","author":"Wilkinson","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd4685","article-title":"Clinical experiences with systemically administered siRNA-based therapeutics in cancer. Nature reviews","volume":"14","author":"Zuckerman","year":"2015","journal-title":"Drug Discov."},{"key":"ref_30","first-page":"Xxxv","article-title":"Are we there yet? An update on oligonucleotide drug development","volume":"34","author":"Ackley","year":"2016","journal-title":"Chim. Oggi."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.jmb.2013.03.007","article-title":"The Role of miRNAs in Regulating Gene Expression Networks","volume":"425","author":"Gurtan","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_33","first-page":"62","article-title":"Argonaute hits-clip decodes microRNA-mRNA interaction maps during heart development","volume":"126","author":"Xu","year":"2013","journal-title":"Cardiology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature08170","article-title":"Argonaute hits-clip decodes microRNA-mRNA interaction maps","volume":"460","author":"Chi","year":"2009","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00018-017-2591-0","article-title":"Stress-induced changes in miRNA biogenesis and functioning","volume":"75","author":"Olejniczak","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA","volume":"316","author":"Sutherland","year":"2007","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2010.09.027","article-title":"MicroRNA Functions in Stress Responses","volume":"40","author":"Leung","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in Stress Signaling and Human Disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s11658-019-0160-2","article-title":"Inhibition of miR-19a protects neurons against ischemic stroke through modulating glucose metabolism and neuronal apoptosis","volume":"24","author":"Ge","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s11658-019-0161-1","article-title":"MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503","volume":"24","author":"Lu","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s11658-019-0155-z","article-title":"MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1","volume":"24","author":"Fu","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s11658-018-0130-0","article-title":"MiR-613 inhibits proliferation and invasion and induces apoptosis of rheumatoid arthritis synovial fibroblasts by direct down-regulation of DKK1","volume":"24","author":"Liu","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s11658-019-0151-3","article-title":"Upregulation of miR-29b-3p protects cardiomyocytes from hypoxia-induced apoptosis by targeting TRAF5","volume":"24","author":"Cai","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s11658-019-0150-4","article-title":"The role of miR-431-5p in regulating pulmonary surfactant expression in vitro","volume":"24","author":"Li","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s11658-019-0146-0","article-title":"MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B","volume":"24","author":"Sun","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s11658-019-0136-2","article-title":"miR-29b-3p regulated osteoblast differentiation via regulating IGF-1 secretion of mechanically stimulated osteocytes","volume":"24","author":"Zeng","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s11658-019-0143-3","article-title":"MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27","volume":"24","author":"Yang","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ma, F., Lin, P., Chen, Q., Lu, X., Zhang, Y.E., and Wu, C.-I. (2018). Direct measurement of pervasive weak repression by microRNAs and their role at the network level. BMC Genom., 19.","DOI":"10.1186\/s12864-018-4757-z"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tcb.2014.11.004","article-title":"The biological functions of miRNAs: Lessons from in vivo studies","volume":"25","author":"Vidigal","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e22412","DOI":"10.1096\/fj.202101987R","article-title":"The hypoxia-induced changes in miRNA-mRNA in RNA-induced silencing complexes and HIF-2 induced miRNAs in human endothelial cells","volume":"36","author":"Moszynska","year":"2022","journal-title":"FASEB J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-018-9600-2","article-title":"miRNAs regulate the HIF switch during hypoxia: A novel therapeutic target","volume":"21","author":"Serocki","year":"2018","journal-title":"Angiogenesis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4149\/neo_2019_190401N282","article-title":"miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review","volume":"67","author":"Guo","year":"2020","journal-title":"Neoplasma"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Cavallari, I., Ciccarese, F., Sharova, E., Urso, L., Raimondi, V., Silic-Benussi, M., D\u2019agostino, D.M., and Ciminale, V. (2021). The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers, 13.","DOI":"10.3390\/cancers13235874"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"965231","DOI":"10.3389\/fonc.2022.965231","article-title":"The role of miR-200 family in the regulation of hallmarks of cancer","volume":"12","author":"Klicka","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.biopha.2012.06.002","article-title":"Review of MiR-200b and cancer chemosensitivity","volume":"66","author":"Feng","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mam.2019.09.005","article-title":"MiR-200 family and cancer: From a meta-analysis view","volume":"70","author":"Huang","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.omtn.2019.06.015","article-title":"Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer","volume":"17","author":"Ginesta","year":"2019","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/bmc-2016-0020","article-title":"The microRNA-200 family: Still much to discover","volume":"7","author":"Senfter","year":"2016","journal-title":"Biomol. Concepts"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"D217","DOI":"10.1093\/nar\/gkac1070","article-title":"MirDIP 5.2: Tissue context annotation and novel microRNA curation","volume":"51","author":"Hauschild","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"D360","DOI":"10.1093\/nar\/gkx1144","article-title":"Mirdip 4.1-integrative database of human microRNA target predictions","volume":"46","author":"Tokar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"Mirtarbase update 2022: An informative resource for experimentally validated miRNA-target interactions","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1055\/s-0029-1233989","article-title":"The prisma statement\u2014What should be reported about systematic reviews?","volume":"134","author":"Antes","year":"2009","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene Set Knowledge Discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr. Protoc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: Gene Set Analysis Toolkit with Revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s40265-021-01582-2","article-title":"Comment on: \u201cMicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19\u201d","volume":"81","author":"Zhang","year":"2021","journal-title":"Drugs"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s11658-019-0196-3","article-title":"Editorial focus: Understanding off-target effects as the key to successful RNAi therapy","volume":"24","author":"Bartoszewski","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2014.10.031","article-title":"Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors","volume":"81","author":"Wang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"131579","DOI":"10.4061\/2011\/131579","article-title":"Synthetic pre-miRNA-based shRNA as potent RNAi triggers","volume":"2011","author":"Terasawa","year":"2011","journal-title":"J. Nucleic Acids"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s11658-018-0111-3","article-title":"Editorial focus: Entering into the non-coding RNA era","volume":"23","author":"Bartoszewski","year":"2018","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-62703-083-0_10","article-title":"Evaluating the microRNA targeting sites by luciferase reporter gene assay","volume":"936","author":"Jin","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s11658-023-00421-4","article-title":"Outside the limit: Questioning the distance restrictions for cooperative miRNA binding sites","volume":"28","author":"Diener","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"16431","DOI":"10.1038\/s41598-018-34861-2","article-title":"PIWI proteins contribute to apoptosis during the UPR in human airway epithelial cells","volume":"8","author":"Gebert","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1007\/s00018-021-03952-1","article-title":"Genome-wide mRNA profiling identifies X-box-binding protein 1 (XBP1) as an IRE1 and PUMA repressor","volume":"78","author":"Gebert","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/febs.15195","article-title":"Genome-wide mRNA profiling identifies RCAN1 and GADD45A as regulators of the transitional switch from survival to apoptosis during ER stress","volume":"287","author":"Bartoszewski","year":"2020","journal-title":"FEBS J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymeth.2007.11.001","article-title":"Inhibition of microRNA with antisense oligonucleotides","volume":"44","author":"Esau","year":"2008","journal-title":"Methods"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/nar\/gkn904","article-title":"Potent inhibition of microRNA in vivo without degradation","volume":"37","author":"Davis","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates","volume":"452","author":"Lindow","year":"2008","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1261\/rna.2533811","article-title":"MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection","volume":"17","author":"Torres","year":"2011","journal-title":"RNA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/nar\/gkm024","article-title":"Specificity, duplex degradation and subcellular localization of antagomirs","volume":"35","author":"Kuwajima","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"147376","DOI":"10.1016\/j.gene.2023.147376","article-title":"EPAS1 resistance to miRNA-based regulation contributes to prolonged expression of hif-2 during hypoxia in human endothelial cells","volume":"868","author":"Jaskiewicz","year":"2023","journal-title":"Gene"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/nprot.2011.423","article-title":"Use of target protector morpholinos to analyze the physiological roles of specific miRNA-mRNA pairs in vivo","volume":"6","author":"Staton","year":"2011","journal-title":"Nat. Protoc."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/156802607780487740","article-title":"Morpholino, siRNA, and S-DNA Compared: Impact of Structure and Mechanism of Action on Off-Target Effects and Sequence Specificity","volume":"7","author":"Summerton","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/oli.1.1996.6.267","article-title":"Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation","volume":"6","author":"Hudziak","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: The case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-6380-5_7","article-title":"RIP: RNA Immunoprecipitation","volume":"1480","author":"Gagliardi","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymeth.2013.11.001","article-title":"Profiling post-transcriptionally networked mRNA subsets using RIP-Chip and RIP-Seq","volume":"67","author":"Jayaseelan","year":"2014","journal-title":"Methods"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the Dependency of Cellular Protein Levels on mRNA Abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12013-014-9885-8","article-title":"Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma","volume":"70","author":"Liu","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1080\/21655979.2021.1923238","article-title":"Delta-tocotrienol suppresses the migration and angiogenesis of trophoblasts in preeclampsia and promotes their apoptosis via miR-429\/ ZEB1 axis","volume":"12","author":"Shi","year":"2021","journal-title":"Bioengineered"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Peng, Z., Ouyang, X., Wang, Y., and Fan, Q. (2022). MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating mir-429\/zeb1 axis. BMC Mol. Cell. Biol., 23.","DOI":"10.1186\/s12860-022-00420-x"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopha.2016.03.035","article-title":"The effects of microRNA-429 on inhibition of cervical cancer cells through targeting zeb1 and crkl","volume":"80","author":"Wang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"36101","DOI":"10.1074\/jbc.M114.598383","article-title":"MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (ASCL2): Impact on the epithelial-mesenchymal transition in colon cancer cells","volume":"289","author":"Tian","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2019.05.021","article-title":"LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression","volume":"113","author":"Shen","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"7974012","DOI":"10.1155\/2021\/7974012","article-title":"LncRNA linc01303 promotes the progression of oral squamous cell carcinomas via the mir-429\/ZEB1\/EMT axis","volume":"2021","author":"Sun","year":"2021","journal-title":"J. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"118480","DOI":"10.1016\/j.lfs.2020.118480","article-title":"Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1","volume":"262","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/CAD.0000000000001295","article-title":"RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma","volume":"33","author":"Liu","year":"2022","journal-title":"Anti-Cancer Drugs"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1096\/fj.14-267054","article-title":"The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1alpha expression in human endothelial cells through a negative feedback loop","volume":"29","author":"Bartoszewska","year":"2015","journal-title":"FASEB J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10529-018-2604-6","article-title":"MiR-429 improved the hypoxia tolerance of human amniotic cells by targeting HIF-1\u03b1","volume":"40","author":"Ge","year":"2018","journal-title":"Biotechnol. Lett."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"22775","DOI":"10.1038\/srep22775","article-title":"miR-429 regulates the transition between Hypoxia-Inducible Factor (HIF)1A and HIF3A expression in human endothelial cells","volume":"6","author":"Bartoszewska","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.3892\/ol.2020.11766","article-title":"MiR-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing WNT\/beta-catenin signaling pathway","volume":"20","author":"Sun","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.abb.2017.11.011","article-title":"MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23","volume":"637","author":"Xue","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnmol.2018.00035","article-title":"MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5","volume":"11","author":"Chen","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbrc.2017.06.181","article-title":"Tacrolimus induces fibroblasts apoptosis and reduces epidural fibrosis by regulating miR-429 and its target of RhoE","volume":"490","author":"Li","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_108","first-page":"92","article-title":"Erratum: MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma","volume":"13","author":"Su","year":"2020","journal-title":"Mol. Clin. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/or.2015.4039","article-title":"MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting pak6\/cofilin signaling","volume":"34","author":"Tian","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"332.e9","DOI":"10.1016\/j.urolonc.2015.03.016","article-title":"MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma","volume":"33","author":"Qiu","year":"2015","journal-title":"Urol. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3892\/ijmm.2016.2558","article-title":"Downregulation of microRNA-429 protects cardiomyocytes against hypoxia-induced apoptosis by increasing Notch1 expression","volume":"37","author":"Xu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/carcin\/bgt089","article-title":"Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells","volume":"34","author":"You","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fonc.2020.01067","article-title":"PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR","volume":"10","author":"Lv","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Wang, Y., Liu, J., Yao, Q., Wang, Y., Liu, Z., and Zhang, L. (2021). LncRNA SNHG6 promotes wilms\u2019 tumor progression through regulating mir-429\/frs2 axis. Cancer Biother. Radiopharm.","DOI":"10.1089\/cbr.2020.3705"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-018-0889-7","article-title":"Circular RNA hsa_circ_0008305 (circptk2) inhibits tgf-beta-induced epithelial-mesenchymal transition and metastasis by controlling tif1gamma in non-small cell lung cancer","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10528-022-10285-6","article-title":"CircLIFR Inhibits Non-small Cell Lung Cancer Progression by Acting as a miR-429 Sponge to Enhance CELF2 Expression","volume":"61","author":"Wang","year":"2023","journal-title":"Biochem. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1002\/jcp.27772","article-title":"Overexpression of MALAT1 contributes to cervical cancer progression by acting as a sponge of miR-429","volume":"234","author":"Shen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_118","first-page":"11399","article-title":"Ln RNA linc01234 promotes triple-negative breast cancer progression through regulating the miR-429\/SYNJ1 axis","volume":"13","author":"Bi","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1447207","DOI":"10.1155\/2022\/1447207","article-title":"LncRNA MSC-AS1\/miRNA-429 axis mediates growth and metastasis of nasopharyngeal carcinoma via JAK1\/STAT3 signaling pathway","volume":"2022","author":"Luo","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3892\/mmr.2021.12323","article-title":"Knockdown of circ-pvt1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR-429\/FOXK1 signaling axis","volume":"24","author":"Cao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.2147\/OTT.S277284","article-title":"LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression","volume":"14","author":"Meng","year":"2021","journal-title":"OncoTargets Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"117323","DOI":"10.1016\/j.lfs.2020.117323","article-title":"Knockdown of circ_0084043 suppresses the development of human melanoma cells through mir-429\/tribbles homolog 2 axis and Wnt\/beta-catenin pathway","volume":"243","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1080\/21655979.2021.1953822","article-title":"Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429","volume":"12","author":"Sun","year":"2021","journal-title":"Bioengineered"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s11658-020-0202-9","article-title":"MicroRNA-429 inhibits neuroblastoma cell proliferation, migration and invasion via the NF-\u03baB pathway","volume":"25","author":"Zhou","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3892\/mmr.2021.12220","article-title":"Anti-inflammatory role of microRNA-429 in human gingival epithelial cells-inhibition of Il-8 production through direct binding to ikkbeta mRNA","volume":"24","author":"Kawasaki","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.omtn.2021.01.026","article-title":"Hfd-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via ezh2-mediated miR-429\/pparalpha axis. Molecular therapy","volume":"24","author":"Zhang","year":"2021","journal-title":"Nucleic Acids"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.7150\/jca.21024","article-title":"Long Non-coding RNA XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429","volume":"8","author":"Cheng","year":"2017","journal-title":"J. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2014.05.084","article-title":"MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes","volume":"450","author":"Lang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2015.04.023","article-title":"MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial\u2013mesenchymal transition","volume":"364","author":"Tang","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"110215","DOI":"10.1016\/j.biopha.2020.110215","article-title":"MiR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through sOS1\/MEK\/ERK\/MMP2\/MMP9 pathway","volume":"127","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/s41598-018-20258-8","article-title":"miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf\/MEK\/ERK pathway and epithelial-mesenchymal transition","volume":"8","author":"Guo","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2013-305715","article-title":"Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4","volume":"64","author":"Li","year":"2015","journal-title":"Gut"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"140216","DOI":"10.1098\/rsos.140216","article-title":"An investigation of the false discovery rate and the misinterpretation of p-values","volume":"1","author":"Colquhoun","year":"2014","journal-title":"R Soc. Open Sci."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Ioannidis, J.P.A. (2005). Why Most Published Research Findings Are False. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020124"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10911-010-9178-9","article-title":"Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression","volume":"15","author":"Micalizzi","year":"2010","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1878-0261.12017","article-title":"Epithelial-mesenchymal transition in tumor metastasis","volume":"11","author":"Yeung","year":"2017","journal-title":"Mol. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/embor.2010.117","article-title":"The ZEB\/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?","volume":"11","author":"Brabletz","year":"2010","journal-title":"EMBO Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/embor.2008.74","article-title":"A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells","volume":"9","author":"Burk","year":"2008","journal-title":"EMBO Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-08-1942","article-title":"A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition","volume":"68","author":"Bracken","year":"2008","journal-title":"Cancer Res"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejcb.2017.10.001","article-title":"miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells","volume":"96","author":"Bartoszewski","year":"2017","journal-title":"Eur. J. Cell Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"84453","DOI":"10.18632\/oncotarget.11497","article-title":"EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells","volume":"7","author":"Cardenas","year":"2016","journal-title":"Oncotarget"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.3748\/wjg.v26.i35.5328","article-title":"RBBP4 promotes colon cancer malignant progression via regulating Wnt\/beta-catenin pathway","volume":"26","author":"Li","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-015-0295-3","article-title":"Notch1 signaling regulates the epithelial\u2013mesenchymal transition and invasion of breast cancer in a Slug-dependent manner","volume":"14","author":"Shao","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-15-1941","article-title":"AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.3748\/wjg.v20.i31.10813","article-title":"Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer","volume":"20","author":"Kyuno","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5483\/BMBRep.2015.48.2.035","article-title":"Tight junction protein 1 is regulated by transforming growth factor-beta and contributes to cell motility in nsclc cells","volume":"48","author":"Lee","year":"2015","journal-title":"BMB Rep."},{"key":"ref_148","first-page":"3482","article-title":"HIF-1\u03b1 promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model","volume":"15","author":"Zhu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1002\/cam4.2667","article-title":"Hypoxia-induced HIF-1alpha and ZEB1 are critical for the malignant transformation of ameloblastoma via TGF-beta-dependent emt","volume":"8","author":"Yoshimoto","year":"2019","journal-title":"Cancer Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"658151","DOI":"10.3389\/fonc.2021.658151","article-title":"Hypoxia-Induced MALAT1 Promotes the Proliferation and Migration of Breast Cancer Cells by Sponging MiR-3064-5p","volume":"11","author":"Shih","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1073\/pnas.0711591105","article-title":"Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways","volume":"105","author":"Zheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2013.10.009","article-title":"Evidence that collaboration between HIF-1\u03b1 and Notch-1 promotes neuronal cell death in ischemic stroke","volume":"62","author":"Cheng","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1479-5876-11-251","article-title":"Notch signaling activation contributes to cardioprotection provided by ischemic preconditioning and postconditioning","volume":"11","author":"Zhou","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3892\/ijo.2016.3630","article-title":"Hypoxia upregulates Malat1 expression through a CaMKK\/AMPK\/HIF-1\u03b1 axis","volume":"49","author":"Miard","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijbiomac.2019.02.041","article-title":"Circular RNA circptk2 regulates oxygen-glucose deprivation-activated microglia-induced hippocampal neuronal apoptosis via miR-29b-sOCS-1-JAK2\/STAT3-IL-1beta signaling","volume":"129","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/s41388-021-01971-7","article-title":"Positive feedback regulation of lncRNA PVT1 and HIF2\u03b1 contributes to clear cell renal cell carcinoma tumorigenesis and metastasis","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"ref_157","first-page":"104","article-title":"Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1\/miR-140-3p\/ATG5 axis","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41419-019-1352-4","article-title":"Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer","volume":"10","author":"Lin","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13046-021-01868-z","article-title":"Long non-coding RNA MAPKAPK5-AS1\/PLAGL2\/HIF-1alpha signaling loop promotes hepatocellular carcinoma progression","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_160","first-page":"6487","article-title":"Long noncoding RNA XIST participates hypoxia-induced angiogenesis in human brain microvascular endothelial cells through regulating miR-485\/SOX7 axis","volume":"11","author":"Hu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12010-022-04165-3","article-title":"Long Noncoding RNA XIST Regulates Myocardial Infarction via miR-486-5p\/SIRT1 Axis","volume":"195","author":"Xie","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"15330338211036304","DOI":"10.1177\/15330338211036304","article-title":"Hypoxia and the Tumor Microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/ijc.29519","article-title":"HIF-1 at the crossroads of hypoxia, inflammation, and cancer","volume":"138","author":"Balamurugan","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The role of hypoxia in the tumor microenvironment and development of cancer stem cell: A novel approach to developing treatment","volume":"21","author":"Nejad","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221611X13176664479287","article-title":"Emerging Role of MicroRNAs in Drug-Resistant Breast Cancer","volume":"15","author":"Majumder","year":"2011","journal-title":"Gene Expr."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1515\/hsz-2016-0308","article-title":"MicroRNAs are important regulators of drug resistance in colorectal cancer","volume":"398","author":"Zhang","year":"2017","journal-title":"Biol. Chem."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Baxter, D.E., Allinson, L.M., Al Amri, W.S., Poulter, J.A., Pramanik, A., Thorne, J.L., Verghese, E.T., and Hughes, T.A. (2021). MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer. Cancers, 13.","DOI":"10.3390\/cancers13235979"},{"key":"ref_168","first-page":"317","article-title":"Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to s-1 in colon cancer","volume":"3","author":"Nakajima","year":"2006","journal-title":"Cancer Genom. Proteom."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Bogutz, A.B., Oh-McGinnis, R., Jacob, K.J., Ho-Lau, R., Gu, T., Gertsenstein, M., Nagy, A., and Lefebvre, L. (2018). Transcription factor ASCL2 is required for development of the glycogen trophoblast cell lineage. PLoS Genet., 14.","DOI":"10.1371\/journal.pgen.1007587"},{"key":"ref_170","first-page":"51","article-title":"Hypoxia-Inducible Factor (HIF)-1 Regulatory Pathway and its Potential for Therapeutic Intervention in Malignancy and Ischemia","volume":"80","author":"Ziello","year":"2007","journal-title":"Yale J. Biol. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","article-title":"Hypoxia-Inducible Factor 1 (HIF-1) Pathway","volume":"2007","author":"Semenza","year":"2007","journal-title":"Sci. STKE"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"22642","DOI":"10.1074\/jbc.272.36.22642","article-title":"Hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: Its stabilization by hypoxia depends on redox-induced changes*","volume":"272","author":"Salceda","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s11658-022-00408-7","article-title":"The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability","volume":"27","author":"Cabaj","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-Inducible Factors in Physiology and Medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"C227","DOI":"10.1152\/ajpcell.00112.2001","article-title":"Reactive species mechanisms of cellular hypoxia-reoxygenation injury","volume":"282","author":"Li","year":"2002","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0925-4773(97)00674-6","article-title":"HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1\u03b1 and developmentally expressed in blood vessels","volume":"63","author":"Flamme","year":"1997","journal-title":"Mech. Dev."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2012.06.004","article-title":"Passing the baton: The HIF switch","volume":"37","author":"Koh","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1096\/fj.201802650RR","article-title":"Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia","volume":"33","author":"Bartoszewski","year":"2019","journal-title":"FASEB J."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fped.2015.00033","article-title":"Hypoxia-Inducible Factor as an Angiogenic Master Switch","volume":"3","author":"Hashimoto","year":"2015","journal-title":"Front. Pediatr."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1alpha is required for solid tumor formation and embryonic vascularization","volume":"17","author":"Ryan","year":"1998","journal-title":"EMBO J."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jacbts.2020.05.006","article-title":"Mutual Antagonism of Hypoxia-Inducible Factor Isoforms in Cardiac, Vascular, and Renal Disorders","volume":"5","author":"Packer","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s00018-019-03387-9","article-title":"A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin","volume":"77","author":"Tolonen","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_186","first-page":"454","article-title":"Hypoxia-inducible factor (HIF)-3a2 serves as an endothelial cell fate executor during chronic hypoxia","volume":"21","author":"Jaskiewicz","year":"2022","journal-title":"EXCLI J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/febs.13572","article-title":"HIF3\u03b1: The little we know","volume":"283","author":"Ravenna","year":"2016","journal-title":"FEBS J."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.biocel.2010.04.008","article-title":"Hypoxia-inducible factor (HIF)-3\u03b1 is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2","volume":"42","author":"Pasanen","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1096\/fj.05-3788com","article-title":"Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma","volume":"19","author":"Maynard","year":"2005","journal-title":"FASEB J."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Bartoszewska, S., Collawn, J.F., and Bartoszewski, R. (2022). The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment. Cancers, 14.","DOI":"10.3390\/cancers14194870"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia--a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1541-7786.MCR-05-0234","article-title":"Akt1 Activation Can Augment Hypoxia-Inducible Factor-1\u03b1 Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin\u2013Independent Pathway","volume":"4","author":"Pore","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1073\/pnas.0706790105","article-title":"PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a)","volume":"105","author":"Emerling","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.14.4.391","article-title":"Loss of PTEN facilitates HIF-1-mediated gene expression","volume":"14","author":"Zundel","year":"2000","journal-title":"Genes Dev."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.4049\/jimmunol.166.12.7543","article-title":"Hypoxia-Inducible Factor 1-Mediated Inhibition of Peroxisome Proliferator-Activated Receptor \u03b1 Expression During Hypoxia","volume":"166","author":"Narravula","year":"2001","journal-title":"J. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1096\/fj.201500094R","article-title":"On the pivotal role of pparalpha in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury","volume":"30","author":"Cole","year":"2016","journal-title":"FASEB J."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","article-title":"Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation","volume":"9","author":"Ramakrishnan","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Park, T. (2021). Crk and CrkL as Therapeutic Targets for Cancer Treatment. Cells, 10.","DOI":"10.3390\/cells10040739"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.1404545111","article-title":"The docking protein Frs2alpha is a critical regulator of Vegf receptors signaling","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2005.01.007","article-title":"TIMP-2: An endogenous inhibitor of angiogenesis","volume":"11","author":"Seo","year":"2005","journal-title":"Trends Mol. Med."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e12307","DOI":"10.1111\/cpr.12307","article-title":"The JAK\/STAT3 signalling pathway regulated angiogenesis in an endothelial cell\/adipose-derived stromal cell co-culture, 3D gel model","volume":"50","author":"Xue","year":"2017","journal-title":"Cell Prolif."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41420-020-0247-6","article-title":"The role of noncoding RNAs in epithelial cancer","volume":"6","author":"Agostini","year":"2020","journal-title":"Cell Death Discov."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"758653","DOI":"10.3389\/fonc.2021.758653","article-title":"Novel Insights into MALAT1 Function as a MicroRNA Sponge in NSCLC","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2007.11.018","article-title":"Members of the miRNA-200 Family Regulate Olfactory Neurogenesis","volume":"57","author":"Choi","year":"2008","journal-title":"Neuron"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"6753926","DOI":"10.1155\/2021\/6753926","article-title":"MiR-429 inhibits the angiogenesis of human brain microvascular endothelial cells through Snai2-mediated Gsk-3beta\/beta-catenin pathway","volume":"2021","author":"Sun","year":"2021","journal-title":"Comput. Math. Methods Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/11\/2903\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:41:38Z","timestamp":1760125298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/11\/2903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":205,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["cancers15112903"],"URL":"https:\/\/doi.org\/10.3390\/cancers15112903","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]}}}